Sienna Logo wR.jpg
Sienna Biopharmaceuticals to Present at Dermatology Drug Development Summit Europe
21. Mai 2019 09:05 ET | Sienna Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., May 21, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that Paul F. Lizzul, M.D.,...
Sienna Logo wR.jpg
Sienna Biopharmaceuticals® to Present at Dermatology Summit and J.P. Morgan Healthcare Conference
02. Januar 2019 16:30 ET | Sienna Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief...